BackChronoScale Overview

ChronoScale Total Assets

Track ChronoScale's total assets ($20M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$19.67M
↓ 27.98% YoYΔ $-7.64M vs prior year quarter

Peer trimmed avg / median

Loading

ChronoScale Total Assets History

Loading

ChronoScale vs. peers: Total Assets Comparison

Loading

ChronoScale Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ChronoScale (CHRN) FAQ

ChronoScale (CHRN) currently reports a total assets of $20M as of March 2026. That compares with $27M in the prior-year period — down 28.0% year over year. Use the charts on this page to explore ChronoScale's total assets history and peer comparisons.

ChronoScale's total assets decreased from $27M to $20M — a 28.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ChronoScale reported $20M in total assets as of March 2026. That compares with $27M in the prior-year period — down 28.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ChronoScale, and consider following CHRN for alerts when major investors trade the stock.

ChronoScale is classified in the Healthcare sector. On total assets, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CHRN with unrelated industries.